Chemical Structure (Levalbuterol Inhalation Solution Usp 1)
Levalbuterol Solution
Product Images NDC 0115-9930
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Levalbuterol (NDC 0115-9930). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure E1 (Levalbuterol Inhalation Solution Usp 10)
Figure E2 (Levalbuterol Inhalation Solution Usp 11)
The text seems to be a label for a product called "FACE MASK RESERVOIR II". It provides no further information about the product or its purpose.*
Figure F (Levalbuterol Inhalation Solution Usp 12)
Figure G1 (Levalbuterol Inhalation Solution Usp 13)
Figure G2 (Levalbuterol Inhalation Solution Usp 14)
0.31mg_3 mL (Levalbuterol Inhalation Solution Usp 15)
This is a description of Levalbuterol Inhalation Solution, USP. Each 3 mL uni-dose vial contains 0.31 mg of levalbuterol provided as an aqueous solution containing sodium chloride, acetate sodium, and sulfuric acid to adjust the pH of the solution to 4.0. It provides quick relief from bronchospasms. The pack contains a "Patient Information Leaflet" and should be used only as directed by a physician. The unit-dose vials should remain stored in the protective pouch at all times. Once the pouch is opened, the vials should be used within two weeks. It is Rx only, and its mart is The Ritedose Corporation Distributed by Amneal Pharmaceuticals LLC.*
0.63 mg_3ml (Levalbuterol Inhalation Solution Usp 16)
This is a product description of Levalbuterol Inhalation Solution, USP. Each 3 mL unit-dose vial contains 0.63 mg aqueous solution containing sodium. The solution is free from preservatives. This product is meant for inhalation use only, directed by a physician, and the recommended dosage must not be exceeded. The product should be stored at controlled room temperature and protected from light. The vials should remain in the protective pouch until use and once removed, they should be discarded after two weeks. The manufacturer is The Ritedose Corporation in South Carolina, and it is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. However, there is some text that is not readable or understandable.*
1.25 mg_3 mL (Levalbuterol Inhalation Solution Usp 17)
Levalbuterol Inhalation Solution, USP is a medication that comes in a unit-dose vial containing 1.25mg of the drug provided as hydrochloric salt in an aqueous solution along with sodium chloride, edetate disodium, and sulfuric acid to adjust the pH of the solution to 4.0. The package insert cautions that it should be used only as directed by a physician and not exceed the recommended dosage. It should be kept out of reach of children and stored in a protective pouch at controlled temperatures. The solution contains no preservatives.*
Figure 1 (Levalbuterol Inhalation Solution Usp 2)
Figure 2 (Levalbuterol Inhalation Solution Usp 3)
Figure 3 (Levalbuterol Inhalation Solution Usp 4)
Figure 4 (Levalbuterol Inhalation Solution Usp 5)
Figure A (Levalbuterol Inhalation Solution Usp 6)
The text indicates that there is a shaded area that indicates the twist-off portion of a unit-dose vial.*
Figure B (Levalbuterol Inhalation Solution Usp 7)
Figure C (Levalbuterol Inhalation Solution Usp 8)
Figure D (Levalbuterol Inhalation Solution Usp 9)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
